secwatch.observer — SEC 8-K summary
======================================

Issuer:     Boundless Bio, Inc. (BOLD)
CIK:        0001782303
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0001193125-25-070496
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boundless Bio enters $14.5M ATM equity distribution agreement with Jefferies
----------------------------------------------------------------------------

- Company may sell up to $14.5M of common stock via at-the-market offerings through Jefferies LLC.
- Shares sold at prevailing market prices; Jefferies receives up to 3.0% commission on gross proceeds.
- No minimum sale obligation; either party may terminate the agreement on prior written notice.
- Issuance is subject to SEC effectiveness of Form S-3 registration statement filed April 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782303/000119312525070496/0001193125-25-070496-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782303/000119312525070496/d945427d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-070496

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer